Advertisement

Journal of Nephrology

, Volume 28, Issue 6, pp 691–700 | Cite as

Evaluating renal biopsy-associated hemorrhage complications by the equation and providing an early intervention: a single-center experience

  • Chao Wang
  • Yang Yang
  • Liping Jin
  • Ying Zhang
  • Guanglei Chen
  • Zhuliang Zhou
  • Minghui Song
  • Qingman Gao
  • Changchun Li
  • Tao Pan
  • Fagui He
  • Lu MaEmail author
Original Article

Abstract

Background

The aim was to evaluate the risk for major hemorrhage complications (MHC) prior to percutaneous renal biopsy and apply a specific procedure in high-risk patients to decrease their incidence. Hemorrhage complications that required blood transfusion or other interventions were diagnosed as MHC.

Methods

One retrospective (Group A, n = 1314) and two prospective cohorts (Group B, n = 249 and Group C, n = 422) were involved in the study. Group A was used to establish a risk equation for MHC, Group B to test its performance, and Group C to evaluate the efficacy of the proposed procedure to reduce MHC incidence. Group C was classified, based on the equation, into high-risk (C1) and low-risk (C2) patients, who received different interventions. The intervention in Group C1 consisted of use of 18-gauge needles, a 12-h rest period post-operation, and reptilase injection; in Group C2, 16-gauge needles were used, with a 6-h rest, and no reptilase injection. Group B was also divided into B1 (high-risk) and B2 (low-risk) using the same cut-off, for further comparison.

Results

(1) In Group A, 4.8 % of patients experienced MHC and the equation: Logit (PMHC) = 0.022 × mean arterial pressure (mmHg) + 0.216 × bleeding time (min) − 0.011 × eGFR [ml/(min 1.73 m2)] − 0.894 × kidney length (cm) − 2.100 × renal cortical thickness (cm) + 6.225 (cutoff = −1.664) was established. (2) The area under the receiver operating characteristic curve was 0.848 (95 % CI 0.797–0.890) for Group B. (3) MHC occurred in 4.8 and 2.8 % of patients in Group B and C, respectively; Group B1 suffered significantly more frequent gross hematuria, hematoma and MHC than Group C1; however, no significant difference except for large hematoma was found between Groups B2 and C2 for all complications.

Conclusions

The equation is reliable to predict the risk for MHC; the interventions proposed can decrease the incidence of MHC in high-risk patients.

Keywords

Biopsy Complications Hemorrhage Risk adjustment Intervention 

Notes

Conflict of interest

All authors declared no conflict of interest on this paper.

Ethical approval

The study was approved by the Health Department Ethics Committee of Beijing Military Region (Code: BH20100125).

Informed consent

All patients needed sign the informed consent before the operation.

References

  1. 1.
    Iversen P, Brun C (1951) Aspiration biopsy of the kidney. Am J Med 11:324–330CrossRefPubMedGoogle Scholar
  2. 2.
    Whittier WL, Korbet SM (2004) Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 15:142–147CrossRefPubMedGoogle Scholar
  3. 3.
    Manno C, Strippoli GF, Arnesano L, Bonifati C, Campobasso N, Gesualdo L, Schena FP (2004) Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 66:1570–1577CrossRefPubMedGoogle Scholar
  4. 4.
    Korbet SM (2012) Nephrology and the percutaneous renal biopsy: a procedure in jeopardy of being lost along the way. Clin J Am Soc Nephrol CJASN 7:1545–1547CrossRefPubMedGoogle Scholar
  5. 5.
    Maixnerova D, Jancova E, Skibova J, Rysava R, Rychlik I, Viklicky O, Merta M, Kolsky A, Reiterova J, Neprasova M, Kidorova J, Honsova E, Tesar V (2015) Nationwide biopsy survey of renal diseases in the czech republic during the years 1994–2011. J Nephrol 28:39–49CrossRefPubMedGoogle Scholar
  6. 6.
    Peces R, de Sousa E, Peces C (2011) Renal biopsies in special situations. Nefrologia 31:627–629PubMedGoogle Scholar
  7. 7.
    Tondel C, Vikse BE, Bostad L, Svarstad E (2012) Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in norway 1988-2010. Clin J Am Soc Nephrol CJASN 7:1591–1597CrossRefPubMedGoogle Scholar
  8. 8.
    Torres Munoz A, Valdez-Ortiz R, Gonzalez-Parra C, Espinoza-Davila E, Morales-Buenrostro LE, Correa-Rotter R (2011) Percutaneous renal biopsy of native kidneys: efficiency, safety and risk factors associated with major complications. Arch Med Sci AMS 7:823–831CrossRefPubMedGoogle Scholar
  9. 9.
    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Simard-Meilleur MC, Troyanov S, Roy L, Dalaire E, Brachemi S (2014) Risk factors and timing of native kidney biopsy complications. Nephron Extra 4:42–49PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Toledo K, Perez MJ, Espinosa M, Gomez J, Lopez M, Redondo D, Ortega R, Aljama P (2010) Complications associated with percutaneous renal biopsy in Spain, 50 years later. Nefrologia 30:539–543PubMedGoogle Scholar
  12. 12.
    Korbet SM, Volpini KC, Whittier WL (2014) Percutaneous renal biopsy of native kidneys: a single-center experience of 1,055 biopsies. Am J Nephrol 39:153–162CrossRefPubMedGoogle Scholar
  13. 13.
    Kim D, Kim H, Shin G, Ku S, Ma K, Shin S, Gi H, Lee E, Yim H (1998) A randomized, prospective, comparative study of manual and automated renal biopsies. Am J Kidney Dis 32:426–431CrossRefPubMedGoogle Scholar
  14. 14.
    Corapi KM, Chen JL, Balk EM, Gordon CE (2012) Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis 60:62–73CrossRefPubMedGoogle Scholar
  15. 15.
    Guerrero-Ramos F, Villacampa-Auba F, Jimenez-Alcaide E, Garcia-Gonzalez L, Ospina-Galeano IA, de la Rosa-Kehrmann F, Rodriguez-Antolin A, Passas-Martinez J, Diaz-Gonzalez R (2014) Renal biopsy with 16 g needle: a safety study. Actas urologicas espanolasGoogle Scholar
  16. 16.
    Constantin A, Brisson ML, Kwan J, Proulx F (2010) Percutaneous us-guided renal biopsy: a retrospective study comparing the 16-gauge end-cut and 14-gauge side-notch needles. J Vasc Interv Radiol JVIR 21:357–361CrossRefPubMedGoogle Scholar
  17. 17.
    Mai J, Yong J, Dixson H, Makris A, Aravindan A, Suranyi MG, Wong J (2013) Is bigger better? A retrospective analysis of native renal biopsies with 16 gauge versus 18 gauge automatic needles. Nephrology (Carlton, Vic) 18:525–530CrossRefGoogle Scholar
  18. 18.
    Joshi SA, Gadre KS, Halli R, Shandilya R (2014) Topical use of hemocoagulase (reptilase): a simple and effective way of managing post-extraction bleeding. Ann Maxillofac Surg 4:119PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Shenoy AK, Ramesh KV, Chowta MN, Adhikari PM, Rathnakar UP (2014) Effects of botropase on clotting factors in healthy human volunteers. Perspect Clin Res 5:71–74PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Eiro M, Katoh T, Watanabe T (2005) Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol 9:40–45CrossRefPubMedGoogle Scholar
  21. 21.
    Pasquariello A, Innocenti M, Batini V, Pasquariello G, Beati S, Rindi S, Paoletti S, Panichi V (2007) Theoretical calculation of optimal depth in the percutaneous native kidney biopsy to drastically reduce bleeding complications and sample inadequacy for histopathological diagnosis. Nephrol Dial Transplant 22:3516–3520CrossRefPubMedGoogle Scholar
  22. 22.
    Maya ID, Allon M (2009) Percutaneous renal biopsy: outpatient observation without hospitalization is safe. Semin Dial 22:458–461PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Carrington CP, Williams A, Griffiths DF, Riley SG, Donovan KL (2011) Adult day-case renal biopsy: a single-centre experience. Nephrol Dial Transplant 26:1559–1563CrossRefPubMedGoogle Scholar

Copyright information

© Italian Society of Nephrology 2015

Authors and Affiliations

  • Chao Wang
    • 1
  • Yang Yang
    • 1
  • Liping Jin
    • 1
  • Ying Zhang
    • 1
  • Guanglei Chen
    • 1
  • Zhuliang Zhou
    • 1
  • Minghui Song
    • 1
  • Qingman Gao
    • 1
  • Changchun Li
    • 1
  • Tao Pan
    • 1
  • Fagui He
    • 1
  • Lu Ma
    • 1
    Email author
  1. 1.Kidney Therapy Center of Traditional Chinese and Western Medicine of Chinese ArmyBeidaihe Sanatorium of Beijing Military RegionQinhuangdaoChina

Personalised recommendations